Sign up for The Periodic by AgencyIQ for the latest chemicals and hazardous substances regulatory updates.
See Ahead of the Curve.
Our team of nonpartisan experts, along with customizable, intelligent, analysis solutions clear a path through complex regulation, helping you accelerate action in your industry and improve business-critical outcomes.
The 25 regulations the FDA plans to release by the end of the year
The White House this week unveiled its biannual update to the list of regulations it has under development, a list known as the Unified Agenda. Included in the list are dozens of regulations the FDA plans to release between now and the end of 2023, including 25 proposed and final regulations tentatively planned for release by the end of 2022.
What you need to know about the House and Senate’s user fee reauthorization bills
AgencyIQ’s team of regulatory policy experts will unpack and analyze the House and Senate’s user fee reauthorization and FDA reform bills, what they would do, what they would mean for different life sciences sectors, and how things may evolve in the coming weeks and months.
CBER planning final guidance on studying multiple versions of cell and gene therapies
The FDA’s Center for Biologics Evaluation and Research (CBER) plans to finalize a guidance document in 2022 focused on recommendations for companies studying multiple versions of a cellular or gene therapy product in early-stage clinical trials, the center announced on June 23.
Visibility into industry movements,
so you can keep up with regulation.
From biotechnology to agriculture, dietary supplements to nanomaterials, and legal and consulting regulations, AgencyIQ makes navigating through complex rules simple. Sources are tailored to your industry’s world, so you can stay plugged in to the regulatory landscape and clearly map out organizational success. Learn more about our regulatory intelligence solution below.
70+
Years of Combined Regulatory Experience
20+
Areas of Research Focus
- Pharmaceuticals
- Biologics
- Advanced Therapies
- Medical Devices
- Diagnostics
- Dietary Supplements
- Blood Products
- Generics/Biosimilars
- OTC products
- Agriculture
- Energy
- Electronics
- Automotive
- Hazardous Waste
- Personal Products
- Household Products
- Chemical Management
- Food Contact Materials
- Pesticides
- Hazardous Substances
- Occupational Exposure Limits
- Globally Harmonized System
Unparalleled Regulatory and Industry Expertise
Regulation is ever-evolving, but you can stay informed and focus your team.
A lack of internal resources and qualified hires can leave you shortsighted. Our team of credentialed experts are on hand offering customized insights from the latest research and reports to help you predict outcomes, act fast, and make an impact.
Essential Analysis and Insights
Get ahead of regulatory movement with concise, well-sourced analysis.
Daily, concise review and synthesis of research and updates help you gain clarity and understanding regarding what’s happening and why it’s important. With over 1,000 regulatory research analyses, ensure a full view of accurate, actionable insights.
Intelligent, Online Workspace
Move the needle on policy with a simple way to collaborate
AgencyIQ’s customizable dashboard and personalized research collection helps you track important content, and enables seamless sharing within your team. Collaboration and workflow tools on a single, holistic platform make it easy to accelerate action in your organization.